SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000899140-19-000232
Filing Date
2019-02-14
Accepted
2019-02-14 15:08:07
Documents
1
Group Members
POINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A, #4 p28080265.htm SC 13G/A 80779
  Complete submission text file 0000899140-19-000232.txt   82448
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-88759 | Film No.: 19605126
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A